CN Patent
CN108473448A — 软膏
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2018-08-31 · 8y expired
What this patent protects
本发明提供了一种软膏。该软膏稳定地包含对于PDE4具有特异性抑制活性并且由以下化学式(11)表示的噁唑化合物。该软膏可以被有效地吸收进入皮肤。
USPTO Abstract
本发明提供了一种软膏。该软膏稳定地包含对于PDE4具有特异性抑制活性并且由以下化学式(11)表示的噁唑化合物。该软膏可以被有效地吸收进入皮肤。
Drugs covered by this patent
- Moizerto (DIFAMILAST) · OTSUKA PHARMACEUTICAL Co., Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.